Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties

Published:2020-03 Issue: Volume:190 Page:112090
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Herrera-Arozamena Clara,Estrada-Valencia Martín^ORCID,Pérez Concepción,Lagartera Laura,Morales-García José A.,Pérez-Castillo Ana,Franco-Gonzalez Juan Felipe^ORCID,Michalska Patrycja,Duarte Pablo,León Rafael,López Manuela G.,Mills Alberto,Gago Federico,García-Yagüe Ángel Juan,Fernández-Ginés Raquel,Cuadrado Antonio,Rodríguez-Franco María Isabel^ORCID

Funder

Spanish Ministry of Science, Innovation and Universities

Spanish Research Agency

European Regional Development Funds

General Council for Research and Innovation of the Community of Madrid and European Structural Funds

Health Institute Carlos III

Spanish Ministry of Education

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference106 articles.

1. Alzheimer’s disease: the challenge of the second century;Holtzman;Sci. Transl. Med.,2011

2. Progress in drug development for Alzheimer’s disease: an overview in relation to mitochondrial energy metabolism;Hroudova;Eur. J. Med. Chem.,2016

3. Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer’s disease brain: a meta-analysis in human pathological specimens;Zabel;Free Radic. Biol. Med.,2018

4. Mitochondria-targeted protective compounds in Parkinson’s and Alzheimer’s diseases;Fernández-Moriano;Oxid. Med. Cell. Long.,2015

5. Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach;Cuadrado;Pharmacol. Rev.,2018

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a potent melatonin-based inhibitor of quinone reductase-2 with neuroprotective and neurogenic properties;European Journal of Medicinal Chemistry;2024-11

2. Innovative pathological network‐based multitarget approaches for Alzheimer's disease treatment;Medicinal Research Reviews;2024-04-28

3. Discovery of a Potent Melatonin-Based Inhibitor of Quinone Reductase-2 with Neuroprotective and Neurogenic Properties;2024

4. The Kelch/Nrf2 Antioxidant System as a Target for Some Marine Fungal Metabolites;Oxygen;2023-09-28

5. Design, Synthesis, In Silico Studies and In Vitro Evaluation of New Indole- and/or Donepezil-like Hybrids as Multitarget-Directed Agents for Alzheimer’s Disease;Pharmaceuticals;2023-08-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3